Antitumor properties of an anti-idiotypic monoclonal antibody in relation to N-glycolyl-containing gangliosides

Oncology Reports

Volumn 7, Issue 4, 2000, Pages 751-756

  Vázquez, Ana María ^a   Gabri, Mariano R ^b   Hernández, Ana María ^a   Alonso, Daniel F ^b   Beausoleil, Irene ^a   Gomez, Daniel E ^b   Pérez, Rolando ^a  

^a CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

^b UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

Author keywords

Anti idiotypic antibodies; Immunotherapy; Metastasis; Monoclonal antibodies; Murine mammary cancer; Murine melanoma

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; GANGLIOSIDE; MONOCLONAL ANTIBODY;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; CANCER INVASION; EXPERIMENTAL MELANOMA; EXPERIMENTAL NEOPLASM; FEMALE; HUMAN; IMMUNOLOGY; LUNG TUMOR; METASTASIS; MOUSE; PATHOLOGY;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; FEMALE; GANGLIOSIDES; HUMANS; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASM INVASIVENESS;

EID: 0034219460     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.4.751     Document Type: Article

References (30)

1. Jerne NK: Towards a network theory of the immune system. Ann Immunol 125C: 373-389, 1974.
2. Herlyn D, Benden A, Kane M, Somasundaram R, Zaloudik J, Sperlagh M, Marks G, Hart E, Ralph C, Wetlendorff M and Mastrangelo M: Anti-idiotype cancer vaccines: pre-clinical and clinical studies. In vivo 5: 615-624, 1991.
3. Herlyn D, Somasundarm R, Li W and Maruyama H: Anti-idiotype cancer vaccines: past and future. Cancer Immunol Immunother 43: 65-76, 1996.
4. Yamamoto S, Yamamoto T, Saxton RE, Hoon DSB and Iric RF: Anti-idiotype monoclonal antibody carrying the internal image of ganglioside GM3. J Natl Cancer Inst 82: 1757-1760, 1990.
5. Chapman PB and Houghton AN: Induction of IgG antibodies against GD3 ganglioside in rabbits by an anti-idiotypic monoclonal antibody. J Clin Invest 88: 186-192, 1991.
6. Cheung NKV, Canete A, Cheung IY, Ye JN and Liu C: Disialoganglioside GD2 anti-idiotypic monoclonal antibodies. Int J Cancer 54: 499-505, 1993.
7. Saleh MN, Stapleton JD, Khazaeli MB and LoBuglio AF: Generation of a human anti-idiotypic antibody that mimics the GD2 antigen. J Immunol 151: 3390-3398, 1993.
8. Jinnohara T, Tsujisaki M, Sasaki S, Hinoda Y, Taniguchi M and Imai K: Anti-tumor effect of internal image bearing anti-idiotypic monoclonal antibody in relation to GM3 ganglioside. Int J Cancer 76: 345-353, 1998.
9. Sen G, Chakraborty M, Foon KA, Reisfeld RA and Bhattacharya-Chatterjee M: Induction of IgG antibodies by an anti-idiotype antibody mimicking disialoganglioside GD2. J Immunotherapy 21: 75-83, 1998.
10. McCaffery M, Yao T-J, Williams L, Livingston PO, Houghton AN and Chapman PB: Immunization of melanoma patients with BEC2 anti-idiotypic monoclonal antibody that mimics GD3 ganglioside: enhanced immunogenicity when combined with adjuvant. Clin Cancer Res 2: 679-686, 1996.
11. Foon KA, Sen G, Hutchins L, Kashala OL, Baral R, Banerjee M, Chakraborty M, Garrison J, Reisfeld RA and Bhattacharya-Chatterjee M: Antibody responses in melanoma patients immunized with an anti-idiotype mimicking disialoganglioside GD2. Clin Cancer Res 4: 1117-1124, 1998.
12. Grant SC, Kris MG, Houghton AN and Chapman PB: Long survival of patients with small cell lung cancer after adjuvant treatment with the anti-idiotypic antibody BEC2 plus bacillus Calmette-Guerin. Clin Cancer Res 5: 1319-1323, 1999.
13. Vázquez AM, Alfonso M, Lanne B, Karlsson K-A, Carr A, Barroso O, Fernández LE, Rengifo E, Lanio ME, Alvarez C, Zeuthen J and Pérez R: Generation of a murine monoclonal antibody specific for N-glycolylneuraminic acid-containing gangliosides that also recognizes sulfated glycolipids. Hybridoma 14: 551-556, 1995.
14. Moreno E, Lanne B, Vázquez AM, Kawashima I, Tai T, Fernández LE, Karlsson K-A, Angström J and Pérez R: Delineation of the epitope recognized by an antibody specific for N-glycolylneuraminic acid-containing gangliosides. Glycobiology 8: 695-705, 1998.
15. Vázquez AM, Pérez A, Hernández AM, Macías A, Alfonso M, Bombino G and Pérez R: Syngeneic anti-idiotypic monoclonal antibodies to an anti-NeuGc-containing ganglioside monoclonal antibody. Hybridoma 17: 527-534, 1998.
16. Raychaudhuri S, Yukihiko S, Chen J-J and Köhler H: Analysis of the idiotypic network in tumor immunity. J Immunol 139: 3902-3910, 1987.
17. Bona CA and Köhler H: Anti-idiotypic antibodies and internal images. In: Probes for Receptor Structure and Function. Vol. 4. Venter JG, Fraser CM and Lindstrom J (eds). Alan R. Liss Inc., New York, pp142-150, 1984.
18. Vázquez AM, Tormo BR, Alfonso M, Velandia A, Fernández LE, Giscombe R, Ansotegui I, Jeddi-Tehrani M, Cedeño M, Toledo AL, Pérez R, Mellstedt H and Biberfeld P: Characterization of ior C5 colorectal tumor associated antigen. Inmunologia 14: 130-132 1995.
19. Alonso DF, Farías EF, Urtreger A, Ladeda V, Vidal MC and Bal de Kier Joffé E: Characterization of F3II, a mammary sarcomatoid carcinoma cell line originated from a mouse adenocarcinoma. J Surg Oncol 62: 288-297, 1996.
20. Andrew SM and Titus JA: Fragmentation of immunoglobulin G. In: Current Protocols in Immunology. Vol. 1. Unit 2.8. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM and Strober W (eds). John Wiley and Sons Inc., New York, pp1-10, 1997.
21. Alonso DF, Farías EF, Ladeda V, Davel L, Puricelli L and Bal de Kier Joffé E: Effects of synthetic urokinase inhibitors on local invasion and metastatic dissemination in a murine mammary tumor model. Breast Cancer Res Treat 40: 209-233, 1996.
22. Alonso DF, Farina HG, Skilton G, Gabri MR, De Lorenzo MS and Gomez DE: Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of mevalonate pathway of cholesterol synthesis. Breast Cancer Res Treat 50: 83-93, 1998.
23. Gabri MR, Lorenzano Menna P, Scursoni AM, Gomez DE and Alonso DF: Role of tumor-derived granulocyte-macrophage colony-stimulating factor in mice bearing a highly invasive and metastatic mammary carcinoma. Pathobiology 67: 180-185, 1999.
24. McGary CT, Miele ME and Welch DR: Highly metastatic 13762NF rat mammary adenocarcinoma cell clones stimulate bone marrow by secretion of granulocyte-macrophage colony-stimulating factor/interleukin-3 activity. Am J Pathol 147: 1668-1681, 1995.
25. Katho Y, Nakamura M, Ohnishi Y, Shimamura K, Ueyama Y and Tamaoki N: Autonomous production of granulocyte-macrophage colony-stimulating factor in tumor xenografts associated with leukocytosis. Br J Cancer 68: 715-719, 1993.
26. Hardy B, Yampolski I, Kovjasin R, Galli M and Novogrodsky A: A monoclonal antibody against a human B lymphoblastoid cell line induces tumor regression in mice. Cancer Res 54: 5793-5796, 1994.
27. Raiter A, Novogrodsky A and Hardy B: Activation of lymphocytes by BAT and anti-CTLA-4: comparison of binding to T and B cells. Immunol Lett 69: 247-251, 1999.
28. Silagi S, Dutkowski R and Schaefer A: In vivo requirement for asialo GM1 and Thy1 positive leukocytes for antitumor effect of rIL-2+/-rIFN-gamma. Anticancer Res 8: 1265-1269, 1988.
29. + β cells in the lungs of euthymic and athymic mice. Immunology 88: 82-89, 1996.
30. Cui J, Shin T, Kawano T, Sato H, Komdo E, Toura I, Kaneko Y, Koseki H, Kanno M and Taniguchi M: Requirement for Va14 NKT cells in IL-12-mediated rejection of tumors. Science 278: 1623-1629, 1997.